At 7.5% CAGR Immunoglobulin Market to Reach $US 17,501 Million in 2025
The global immunoglobulin was valued at $9,851 million in 2017, and is projected to reach $17,501 million by 2025, registering a CAGR of 7.5% from 2018 to 2025.
The segmentation of global market by product the research covers IgG, IgA, IgM, IgE and IgD. Also, by mode of delivery Intravenous (5% Concentration, 10% Concentration and others), Sucutaneous (16.5% Concentration, 20% Concentration and others.
Get a Sample Copy of this report: https://bit.ly/2R3VY8r
The top major companies have been profiled in this research report such as Baxter international Inc., CSL Ltd., Grifols S.A., Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., Shire Plc. (Baxalta) and Bayer AG.